By Himiyer | March 27, 2026
Table of Contents
What Happened
FDA announced a public meeting for March 27, 2026 focused on the scope of dietary supplement ingredients under DSHEA. The agency said the meeting would help inform its next steps on the meaning of dietary ingredient categories and would cover issues including the scope of the phrase about increasing total dietary intake, new methodologies to produce existing ingredients, and ingredient types such as proteins, enzymes, and microbials.
Why It Matters
This is a policy story with real commercial implications. Decisions about what qualifies as a lawful dietary ingredient can affect future product development, innovation, and enforcement. For supplement buyers, it is a sign that ingredient legitimacy and regulatory boundaries are still evolving in important categories.
What To Watch
Watch how FDA frames existing ingredients made with new production methods and how it discusses proteins, enzymes, and microbials. Those signals may shape which next-generation products reach the market and how companies position them going forward.
